Shokeikan to Hold Summer Special Exhibition Starting June 2nd

News Highlights

Shokeikan will hold its summer special exhibition starting June 2nd, 2026. This news suggests the necessity of business succession in medical institutions and the importance of considering it early. It mentions the possibility of continuing the business through third-party succession, not just closure or廃業 (going out of business), and emphasizes the value of preparing for 5-10 year periods starting around age 60 for chairpersons and directors. The utilization of specialized advisors focused on the medical industry is also recommended.

Perspective from M&A Medical Editorial Department

While the specific facility name “Shokeikan” is mentioned, this news conveys a highly realistic message: medical institution managers, especially chairpersons and directors, should prepare for business succession over a “5-10 year span” starting around age 60. Behind the news of a summer exhibition event, one should read the importance of early consideration of “third-party succession” as an option beyond closure or 廃業. In other words, it is inferred that this is not merely an event announcement but has a strong aspect of raising awareness among managers about their “exit strategy.” For many medical institutions facing the challenge of a lack of successors, early consultation with specialized advisors (such as medical M&A intermediaries) is suggested as the key to opening a new path for business continuation, rather than simply closing down.

Points Raised by This News

• The special exhibition at “Shokeikan” is a symbolic event prompting awareness of business succession issues in medical institutions.
• Preparing for business succession over a 5-10 year span starting around age 60 is a concrete measure against the risk of lacking successors.
• The importance of "third-party succession" as an option other than closure or business cessation is highlighted.
• Utilizing advisors specialized in the medical industry is an indispensable element for smooth business continuation.

Practical Questions Arising from This News

• What is the specific content of “Shokeikan’s” summer special exhibition, and what are the expected impacts on visitor numbers and revenue?
• What specific steps should chairpersons and directors take when preparing for business succession starting around age 60?
• What specific types of institutions are considered specialized advisors for the medical industry, and what kind of support can be received from them?

If You Feel “Should I Consult Too?”

If the chairperson or director of your clinic or hospital is over 60, has no apparent successor, or feels anxious about future business continuity, this news is a sign to “act early.” Closure or 廃業 is a last resort, and typically a preparation period of 5-10 years is necessary to achieve smooth third-party succession while maintaining business value. Taking this news as an opportunity, we strongly recommend first consulting with an expert familiar with medical M&A to discuss your institution’s current situation and future options in detail.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success fee system as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here